These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31012853)

  • 1. Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial.
    Hein R; Gross L; Aradi D; Rieber J; Hadamitzky M; Merkely B; Huczek Z; Ince H; Hummel A; Baylacher M; Massberg S; Trenk D; Sibbing D;
    EuroIntervention; 2019 Aug; 15(6):e513-e521. PubMed ID: 31012853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
    Sibbing D; Aradi D; Jacobshagen C; Gross L; Trenk D; Geisler T; Orban M; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Holdt L; Felix SB; Parma R; Klopotowski M; Schwinger RHG; Rieber J; Huber K; Neumann FJ; Koltowski L; Mehilli J; Huczek Z; Massberg S;
    Lancet; 2017 Oct; 390(10104):1747-1757. PubMed ID: 28855078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.
    Sibbing D; Aradi D; Jacobshagen C; Gross L; Trenk D; Geisler T; Orban M; Gori T; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Thalmeier A; Löw A; Holdt L; Teupser D; Ince H; Felix SB; Parma R; Malek L; Horstkotte J; Baylacher M; Schwinger R; Rieber J; Mudra H; Hausleiter J; Huber K; Neumann FJ; Koltowski L; Huczek Z; Mehilli J; Massberg S;
    Thromb Haemost; 2017 Jan; 117(1):188-195. PubMed ID: 27652610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial.
    Sibbing D; Gross L; Trenk D; Jacobshagen C; Geisler T; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Parma R; Felix SB; Neumann FJ; Hausleiter J; Baylacher M; Koltowski L; Mehilli J; Huber K; Huczek Z; Aradi D; Massberg S;
    Eur Heart J; 2018 Aug; 39(29):2749-2758. PubMed ID: 29912422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial.
    Koltowski L; Tomaniak M; Gross L; Rymuza B; Kowara M; Parma R; Komosa A; Klopotowski M; Jacobshagen C; Gori T; Aradi D; Huber K; Hadamitzky M; Massberg S; Lesiak M; Filipiak KJ; Witkowski A; Opolski G; Huczek Z; Sibbing D
    J Thromb Thrombolysis; 2019 Apr; 47(3):427-435. PubMed ID: 30739305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trial.
    Orban M; Trenk D; Geisler T; Rieber J; Hadamitzky M; Gross L; Orban M; Kupka D; Baylacher M; Müller S; Huber K; Koltowski L; Huczek Z; Heyn J; Jacobshagen C; Aradi D; Massberg S; Sibbing D; Hein R;
    Eur Heart J Cardiovasc Pharmacother; 2020 Nov; 6(6):372-381. PubMed ID: 31855244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial.
    Aradi D; Gross L; Trenk D; Geisler T; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Ruzsa Z; Ungi I; Rizas KD; May AE; Mügge A; Zeiher AM; Holdt L; Huber K; Neumann FJ; Koltowski L; Huczek Z; Hadamitzky M; Massberg S; Sibbing D
    Eur Heart J; 2019 Jun; 40(24):1942-1951. PubMed ID: 31226213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
    Kim HS; Kang J; Hwang D; Han JK; Yang HM; Kang HJ; Koo BK; Rhew JY; Chun KJ; Lim YH; Bong JM; Bae JW; Lee BK; Park KW;
    Lancet; 2020 Oct; 396(10257):1079-1089. PubMed ID: 32882163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender Substudy.
    Gross L; Kupka D; Trenk D; Geisler T; Hadamitzky M; Löw A; Orban M; Huber K; Kiss RG; Merkely B; Huczek Z; Beuthner BE; Hein-Rothweiler R; Baylacher M; Rizas K; Massberg S; Aradi D; Sibbing D; Jacobshagen C
    Thromb Haemost; 2019 Sep; 119(9):1527-1538. PubMed ID: 31226717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
    Kang J; Rizas KD; Park KW; Chung J; van den Broek W; Claassens DMF; Choo EH; Aradi D; Massberg S; Hwang D; Han JK; Yang HM; Kang HJ; Chang K; Ten Berg JM; Sibbing D; Koo BK; Kim HS
    Eur Heart J; 2023 Apr; 44(15):1360-1370. PubMed ID: 36883613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis.
    Tavenier AH; Mehran R; Chiarito M; Cao D; Pivato CA; Nicolas J; Beerkens F; Nardin M; Sartori S; Baber U; Angiolillo DJ; Capodanno D; Valgimigli M; Hermanides RS; van 't Hof AWJ; Ten Berg JM; Chang K; Kini AS; Sharma SK; Dangas G
    Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):492-502. PubMed ID: 34459481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
    Freynhofer MK; Hein-Rothweiler R; Haller PM; Aradi D; Dézsi DA; Gross L; Orban M; Trenk D; Geisler T; Huczek Z; Toth-Gayor GG; Massberg S; Huber K; Sibbing D
    Thromb Haemost; 2019 Apr; 119(4):660-667. PubMed ID: 30695790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy.
    Gross L; Trenk D; Jacobshagen C; Krieg A; Gawaz M; Massberg S; Baylacher M; Aradi D; Stimpfle F; Hromek J; Vogelgesang A; Hadamitzky M; Sibbing D; Geisler T
    Thromb Haemost; 2018 Sep; 118(9):1656-1667. PubMed ID: 30103241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes.
    Shoji S; Kuno T; Fujisaki T; Takagi H; Briasoulis A; Deharo P; Cuisset T; Latib A; Kohsaka S
    J Am Coll Cardiol; 2021 Aug; 78(8):763-777. PubMed ID: 34275697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Galli M; Benenati S; Capodanno D; Franchi F; Rollini F; D'Amario D; Porto I; Angiolillo DJ
    Lancet; 2021 Apr; 397(10283):1470-1483. PubMed ID: 33865495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
    Deharo P; Quilici J; Camoin-Jau L; Johnson TW; Bassez C; Bonnet G; Fernandez M; Ibrahim M; Suchon P; Verdier V; Fourcade L; Morange PE; Bonnet JL; Alessi MC; Cuisset T
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2560-2570. PubMed ID: 29268886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial.
    Lee KS; Park KH; Park KW; Rha SW; Hwang D; Kang J; Han JK; Yang HM; Kang HJ; Koo BK; Lee NH; Rhew JY; Chun KJ; Lim YH; Bong JM; Bae JW; Lee BK; Kim SY; Shin WY; Lim HS; Park K; Kim HS
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):262-270. PubMed ID: 36715152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.
    Kuno T; Fujisaki T; Shoji S; Sahashi Y; Tsugawa Y; Iwagami M; Takagi H; Briasoulis A; Deharo P; Cuisset T; Latib A; Kohsaka S; Bhatt DL
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e011990. PubMed ID: 35899618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
    Ozawa T; Suda M; Ikegami R; Takano T; Wakasugi T; Yanagawa T; Tanaka K; Ozaki K; Hirono S; Minamino T
    Int Heart J; 2018 Jan; 59(1):21-26. PubMed ID: 29279531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De-escalation of oral P2Y
    Capranzano P; Angiolillo DJ
    EuroIntervention; 2019 Aug; 15(6):e486-e489. PubMed ID: 31395576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.